A Stock Overview
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Agilent Technologies Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$144.68|
|52 Week High||US$179.57|
|52 Week Low||US$112.47|
|1 Month Change||-4.45%|
|3 Month Change||-7.03%|
|1 Year Change||14.63%|
|3 Year Change||101.14%|
|5 Year Change||205.30%|
|Change since IPO||238.43%|
Recent News & Updates
Is Now An Opportune Moment To Examine Agilent Technologies, Inc. (NYSE:A)?
Today we're going to take a look at the well-established Agilent Technologies, Inc. ( NYSE:A ). The company's stock...
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Does This Valuation Of Agilent Technologies, Inc. (NYSE:A) Imply Investors Are Overpaying?
How far off is Agilent Technologies, Inc. ( NYSE:A ) from its intrinsic value? Using the most recent financial data...
|A||US Life Sciences||US Market|
Return vs Industry: A exceeded the US Life Sciences industry which returned 9.6% over the past year.
Return vs Market: A matched the US Market which returned 13.7% over the past year.
|A Average Weekly Movement||3.4%|
|Life Sciences Industry Average Movement||8.7%|
|Market Average Movement||6.6%|
|10% most volatile stocks in US Market||15.9%|
|10% least volatile stocks in US Market||2.4%|
Stable Share Price: A is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: A's weekly volatility (3%) has been stable over the past year.
About the Company
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide.
Agilent Technologies Fundamentals Summary
|A fundamental statistics|
Is A overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A income statement (TTM)|
|Cost of Revenue||US$2.91b|
Last Reported Earnings
Oct 31, 2021
Next Earnings Date
Feb 22, 2022
|Earnings per share (EPS)||4.01|
|Net Profit Margin||19.15%|
How did A perform over the long term?See historical performance and comparison
0.6%Current Dividend Yield
Is Agilent Technologies undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: A ($144.68) is trading above our estimate of fair value ($138.62)
Significantly Below Fair Value: A is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: A is good value based on its PE Ratio (36.1x) compared to the US Life Sciences industry average (39.9x).
PE vs Market: A is poor value based on its PE Ratio (36.1x) compared to the US market (17.4x).
Price to Earnings Growth Ratio
PEG Ratio: A is poor value based on its PEG Ratio (4.5x)
Price to Book Ratio
PB vs Industry: A is overvalued based on its PB Ratio (8.1x) compared to the US Life Sciences industry average (3.3x).
How is Agilent Technologies forecast to perform in the next 1 to 3 years based on estimates from 15 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A's forecast earnings growth (8% per year) is above the savings rate (2%).
Earnings vs Market: A's earnings (8% per year) are forecast to grow slower than the US market (13% per year).
High Growth Earnings: A's earnings are forecast to grow, but not significantly.
Revenue vs Market: A's revenue (6.2% per year) is forecast to grow slower than the US market (9.3% per year).
High Growth Revenue: A's revenue (6.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A's Return on Equity is forecast to be high in 3 years time (26.6%)
How has Agilent Technologies performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A has high quality earnings.
Growing Profit Margin: A's current net profit margins (19.1%) are higher than last year (13.5%).
Past Earnings Growth Analysis
Earnings Trend: A's earnings have grown by 16.7% per year over the past 5 years.
Accelerating Growth: A's earnings growth over the past year (68.3%) exceeds its 5-year average (16.7% per year).
Earnings vs Industry: A earnings growth over the past year (68.3%) underperformed the Life Sciences industry 72.2%.
Return on Equity
High ROE: A's Return on Equity (22.5%) is considered high.
How is Agilent Technologies's financial position?
Financial Position Analysis
Short Term Liabilities: A's short term assets ($3.8B) exceed its short term liabilities ($1.7B).
Long Term Liabilities: A's short term assets ($3.8B) exceed its long term liabilities ($3.6B).
Debt to Equity History and Analysis
Debt Level: A's net debt to equity ratio (21.4%) is considered satisfactory.
Reducing Debt: A's debt to equity ratio has increased from 44.9% to 50.6% over the past 5 years.
Debt Coverage: A's debt is well covered by operating cash flow (54.4%).
Interest Coverage: A's interest payments on its debt are well covered by EBIT (17.8x coverage).
What is Agilent Technologies's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: A's dividend (0.58%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.32%).
High Dividend: A's dividend (0.58%) is low compared to the top 25% of dividend payers in the US market (3.44%).
Stability and Growth of Payments
Stable Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are stable.
Growing Dividend: A is not paying a notable dividend for the US market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: A is not paying a notable dividend for the US market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of A's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mike McMullen (60 yo)
Mr. Michael R. McMullen, also known as Mike, has been the President of Agilent Technologies, Inc., since September 17, 2014 and Chief Executive Officer since March 18, 2015. Mr. McMullen has been a Directo...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD13.61M) is about average for companies of similar size in the US market ($USD11.18M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
Experienced Management: A's management team is seasoned and experienced (7 years average tenure).
Experienced Board: A's board of directors are considered experienced (6.3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: A insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Agilent Technologies, Inc.'s employee growth, exchange listings and data sources
- Name: Agilent Technologies, Inc.
- Ticker: A
- Exchange: NYSE
- Founded: 1999
- Industry: Life Sciences Tools and Services
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: US$43.693b
- Shares outstanding: 302.00m
- Website: https://www.agilent.com
Number of Employees
- Agilent Technologies, Inc.
- 5301 Stevens Creek Boulevard
- Santa Clara
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/01/17 23:13|
|End of Day Share Price||2022/01/14 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.